Posted in | News

Cellular Concrete Technologies Introduces Non-Shrinking Flowable Fill

Cellular Concrete Technologies, which has designed an efficient air-entrainment system, is now introducing a new finding in flowable fill.

The Stable Air system has been highly effective in the construction industry for low cost, high-efficiency and environmentally safe materials. Eric Stovner, Breiholz Qazi Engineering’s LEED AP, said that Stable Air Cellular Concrete Technology is a Green technology that provides both immediate and long-term cost savings and sustainable benefits.

CCT’s patented Stable Air technology maintains air volume within a range of 2% the start of mixing through transit, placement and completion. Stable Air minimizes weight while retaining strength, maximizes freeze/thaw damage protection, optimizes flowability and workability, resists mold and water damage and yields flowable fill without shrinking. This green technology, which is biodegradable and non-toxic, makes environment-friendly construction affordable and easy.

The non-shrinking flowable fill from CCT is considered a superior product globally. Since normal fill mixes comprise 35% air and remaining sand, a standard pour will be for a maximum of 4 ft provided it does not collapse due to its own weight. On the other hand, flowable fill composed of Stable Air can have up to 80% air and reach more than 10 ft in one pour. As most flowable fill batch designs are blended at a 40:1 ratio, the flowable fill made with Stable Air can be blended at a 120:1 ratio. Therefore, with the same amount of fill, foam agent can be produced less than three times.

CCT is hoping to introduce its newest materials at the 2012 World of Concrete convention that will be held in Las Vegas, Nevada, and is being considered for the World of Concrete’s Most Innovative Product award.


Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Cellular Concrete Technologies Introduces Non-Shrinking Flowable Fill. AZoBuild. Retrieved on March 05, 2024 from

  • MLA

    Scanlon, Joel. "Cellular Concrete Technologies Introduces Non-Shrinking Flowable Fill". AZoBuild. 05 March 2024. <>.

  • Chicago

    Scanlon, Joel. "Cellular Concrete Technologies Introduces Non-Shrinking Flowable Fill". AZoBuild. (accessed March 05, 2024).

  • Harvard

    Scanlon, Joel. 2019. Cellular Concrete Technologies Introduces Non-Shrinking Flowable Fill. AZoBuild, viewed 05 March 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.